BioPharma Credit PLC Transaction in Own Shares (1506M)
10 January 2023 - 5:15AM
UK Regulatory
TIDMBPCR
RNS Number : 1506M
BioPharma Credit PLC
09 January 2023
BioPharma Credit plc
(the "Company")
TRANSACTION IN OWN SHARES
BioPharma Credit PLC (the "Company") announces that today it has
purchased the following number of its ordinary shares of US$0.01
each on the London Stock Exchange through J.P. Morgan Securities
plc into treasury.
Ordinary Shares: BPCR LN
Date of purchase: 9 January 2023
Number of ordinary shares purchased: 523,783
Lowest price per share: $0.9460
Highest price per share: $0.9500
Trading venue: JPSI
Aggregate volume per date per trading venue: 523,783
Weighted average price per day per trading venue: $0.9496
Following the above transaction, the Company holds 55,277,181 of
its ordinary shares in treasury and has 1,318,654,886 ordinary
shares in issue (excluding treasury shares). Therefore, the total
number of voting rights in the Company is 1,318,654,886. This
figure may be used by shareholders as the denominator for the
calculations by which they will determine if they are required to
notify their interest in, or a change to their interest in, the
Company under the FCA's Disclosure Guidance and Transparency
Rules.
Enquiries:
BioPharma Credit plc
via Link Company Matters Limited
Company Secretary
+44 (0)1392 477 500
Buchanan
David Rydell / Mark Court / Jamie Hooper / Henry Wilson
+44 (0)20 7466 5000
biopharmacredit@buchanan.uk.com
Notes to Editors:
BioPharma Credit PLC is London's only listed specialist investor
in debt from the life sciences industry and joined the LSE on 27
March 2017. The Company seeks to provide long-term shareholder
returns, principally in the form of sustainable income
distributions from exposure to the life sciences industry. The
Company seeks to achieve this objective primarily through
investments in debt assets secured by royalties or other cash flows
derived from the sales of approved life sciences products.
LEI: 213800AV55PYXAS7SY24
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
POSDKLFBXFLFBBF
(END) Dow Jones Newswires
January 09, 2023 13:15 ET (18:15 GMT)
Biopharma Credit (LSE:BPCR)
Historical Stock Chart
From Apr 2024 to May 2024
Biopharma Credit (LSE:BPCR)
Historical Stock Chart
From May 2023 to May 2024